Pro Share Advisors LLC Kura Oncology, Inc. Transaction History
Pro Share Advisors LLC
- $39.7 Billion
- Q3 2024
A detailed history of Pro Share Advisors LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 18,230 shares of KURA stock, worth $164,252. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,230
Previous 14,155
28.79%
Holding current value
$164,252
Previous $291,000
22.34%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding KURA
# of Institutions
185Shares Held
81.8MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$69 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$62.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$52.3 Million4.92% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$48.8 Million1.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.33MShares$39 Million3.05% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $603M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...